Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy

• Status: Unknown status
• Trial end date: 2013-10-01
• Target enrollment: 0
• Participant gender: Female

Summary

After resection of lymph node positive breast cancer, the injection duration and timing of Granulocyte-colony stimulating factor (G-CSF) could affect the neutropenia with TAC (Taxotere, Adriamycin, cyclophosphamide) chemotherapy.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hyuk moon Kim
• Collaborator: Dong-A Pharmaceutical Co., Ltd.
• Treatments: Lenograstim

Criteria

Inclusion Criteria:

• primary invasive breast carcinoma with lymph node positive with curative surgery with TAC chemotherapy

Exclusion Criteria:

• pregnancy,

• cardiovascualr disease,

• abnormal renal function,

• hematologic disorder